The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $94.54

Today's change-1.56 -1.62%
Updated October 23 3:56 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $94.54

Today's change-1.56 -1.62%
Updated October 23 3:56 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc down (U.S.)$1.56

AbbVie Inc closed sharply lower Monday, dropping (U.S.)$1.56 or 1.62% to (U.S.)$94.54. Over the last five days, shares have gained 3.84% and are currently 3.79% off of the 52-week high. Shares have outperformed the S&P 500 by 35.23% during the last year.

Key company metrics

  • Open(U.S.) $95.93
  • Previous close(U.S.) $96.10
  • High(U.S.) $96.00
  • Low(U.S.) $94.52
  • Bid / Ask(U.S.) $94.53 / (U.S.) $94.54
  • YTD % change+50.97%
  • Volume3,651,905
  • Average volume (10-day)6,290,004
  • Average volume (1-month)7,635,688
  • Average volume (3-month)6,093,433
  • 52-week range(U.S.) $55.06 to (U.S.) $98.26
  • Beta1.54
  • Trailing P/E23.09×
  • P/E 1 year forward17.39×
  • Forward PEG1.24×
  • Indicated annual dividend(U.S.) $2.56
  • Dividend yield2.71%
  • Trailing EPS(U.S.) $4.09
Updated October 23 3:56 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.03%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue6,9446,5386,7966,432
Total other revenue--------
Total revenue6,9446,5386,7966,432
Gross profit5,3964,9315,2444,924
Total cost of revenue1,5481,6071,5521,508
Total operating expense4,2704,1194,4384,071
Selling / general / administrative1,4991,3591,6531,381
Research & development1,2201,1331,1901,106
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)49374080
Other operating expenses, total--------
Operating income2,6742,4192,3582,361
Interest income (expense), net non-operating-284-273-316-271
Gain (loss) on sale of assets--------
Other--------
Income before tax2,3532,0861,9982,014
Income after tax1,9151,7111,3911,598
Income tax, total438375607416
Net income1,9151,7111,3911,598
Total adjustments to net income--------
Net income before extra. items1,9151,7111,3911,598
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,9151,7111,3911,598
Inc. avail. to common incl. extra. items1,9151,7111,3911,598
Diluted net income1,9151,7111,3911,598
Dilution adjustment--------
Diluted weighted average shares1,6001,6031,6251,640
Diluted EPS excluding extraordinary itemsvalue per share1.201.070.860.97
Dividends per sharevalue per share0.640.640.570.57
Diluted normalized EPSvalue per share1.221.090.881.02